Seminars in Fetal & Neonatal Medicine

Papers
(The TQCC of Seminars in Fetal & Neonatal Medicine is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications116
Have outcomes following extremely preterm birth improved over time?62
Using rising tides to lift all boats: Equity-focused quality improvement as a tool to reduce neonatal health disparities47
Prevention of preeclampsia44
Neonatal encephalopathy: Focus on epidemiology and underexplored aspects of etiology43
International comparisons of neurodevelopmental outcomes in infants born very preterm38
Long-term motor outcomes of very preterm and/or very low birth weight individuals without cerebral palsy: A review of the current evidence28
Mechanisms of brain injury in newborn infants associated with the fetal inflammatory response syndrome28
Early developmental interventions for infants born very preterm – what works?28
Mental health outcomes of adults born very preterm or with very low birth weight: A systematic review26
Genetic and epigenetic factors and early life inflammation as predictors of neurodevelopmental outcomes26
Neuroimaging in the term newborn with neonatal encephalopathy24
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns24
Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury22
Neonatal encephalopathy: Etiologies other than hypoxic-ischemic encephalopathy22
Unanswered questions regarding therapeutic hypothermia for neonates with neonatal encephalopathy20
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia19
Management of Neonatal Hypotension and Shock19
Update on mechanisms of the pathophysiology of neonatal encephalopathy18
Need for more evidence in the prevention and management of perinatal asphyxia and neonatal encephalopathy in low and middle-income countries: A call for action18
Neurodevelopmental origins of social competence in very preterm children18
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?18
“Health, wealth and achievements of former very premature infants in adult life”17
LISA/MIST: Complex clinical problems almost never have easy solutions17
Neurologic outcome after fetal inflammatory response syndrome: Trimester-specific considerations17
Prevention of postpartum hemorrhage17
Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations16
Placental contribution to neonatal encephalopathy15
Supporting families in their child's journey with neonatal encephalopathy and therapeutic hypothermia15
Respiratory support of infants born at 22–24 weeks of gestational age14
Superior vena cava flow: Role, assessment and controversies in the management of perinatal perfusion14
A systematic review of reports of quality improvement for bronchopulmonary dysplasia14
Management of comfort and sedation in neonates with neonatal encephalopathy treated with therapeutic hypothermia14
Application and potential of artificial intelligence in neonatal medicine13
Neurological and developmental outcomes following neonatal encephalopathy treated with therapeutic hypothermia13
The neurobiological correlates of cognitive outcomes in adolescence and adulthood following very preterm birth13
Neonatal white matter damage and the fetal inflammatory response13
Inter-center variability in neonatal outcomes of preterm infants: A longitudinal evaluation of 298 neonatal units in 11 countries12
Bedside and laboratory neuromonitoring in neonatal encephalopathy12
Pulmonary hypertension and oxidative stress: Where is the link?12
Infection prevention for extremely low birth weight infants in the NICU12
The use of data in resource limited settings to improve quality of care11
Proposing a care practice bundle for neonatal encephalopathy during therapeutic hypothermia11
Arterial spin labeling perfusion in neonates11
Evidence and practical aspects of treatment with the Tübingen palatal plate11
Nutrition and management of glycemia in neonates with neonatal encephalopathy treated with hypothermia10
Perinatal asphyxia from the obstetric standpoint10
Patent ductus arteriosus and cerebral, cardiac, and gut hemodynamics in premature neonates10
Diagnosis & management of pulmonary hypertension in congenital diaphragmatic hernia10
Management of seizures in neonates with neonatal encephalopathy treated with hypothermia10
Patent ductus arteriosus management and the drift towards therapeutic nihilism – What is the evidence?10
National and international guidelines for neonatal caffeine use: Are they evidenced-based?9
Fluid management, electrolytes imbalance and renal management in neonates with neonatal encephalopathy treated with hypothermia9
Cesarean delivery in low- and middle-income countries: A review of quality of care metrics and targets for improvement9
Late adolescent & young adult functioning and participation outcomes after prematurity9
Assessment of neonatal perfusion9
When to say no to inhaled nitric oxide in neonates?9
Early developmental screening and intervention for high-risk neonates - From research to clinical benefits9
Escaping the Finnegan – Is it time?8
The role of bedside functional echocardiography in the assessment and management of pulmonary hypertension8
Outcomes from the other side8
Challenges in respiratory management during therapeutic hypothermia for neonatal encephalopathy8
Harnessing mobile technology to deliver evidence-based maternal-infant care8
Closing the evidence to practice gap in neonatal transfusion medicine8
Pregnancy and Severe ARDS with COVID-19: Epidemiology, Diagnosis, Outcomes and Treatment8
FIRS: Neonatal considerations8
0.019683122634888